As epigenetic silencing decreases Th1-type chemokines to limit effector T-cell trafficking to the tumor, ICB in combination with inhibitors of EZH2 and DNMT1 slows cancer progression in ID8 ovarian cancer [7] and CT26 colon models [120]. This evidence concerns the gene DNMT1 and neoplasm.